| Literature DB >> 33563983 |
Philip J M Brouwer1, Aleksandar Antanasijevic2, Marlon de Gast1, Joel D Allen3, Tom P L Bijl1, Anila Yasmeen4, Rashmi Ravichandran5,6, Judith A Burger1, Gabriel Ozorowski2, Jonathan L Torres2, Celia LaBranche7, David C Montefiori7, Rajesh P Ringe4,8, Marit J van Gils1, John P Moore4, Per Johan Klasse4, Max Crispin3, Neil P King9,10, Andrew B Ward11, Rogier W Sanders12,13.
Abstract
The HIV-1 envelope glycoprotein trimer is poorly immunogenic because it is covered by a dense glycan shield. As a result, recombinant Env glycoproteins generally elicit inadequate antibody levels that neutralize clinically relevant, neutralization-resistant (Tier-2) HIV-1 strains. Multivalent antigen presentation on nanoparticles is an established strategy to increase vaccine-driven immune responses. However, due to nanoparticle instability in vivo, the display of non-native Env structures, and the inaccessibility of many neutralizing antibody (NAb) epitopes, the effects of nanoparticle display are generally modest for Env trimers. Here, we generate two-component self-assembling protein nanoparticles presenting twenty SOSIP trimers of the clade C Tier-2 genotype 16055. We show in a rabbit immunization study that these nanoparticles induce 60-fold higher autologous Tier-2 NAb titers than the corresponding SOSIP trimers. Epitope mapping studies reveal that the presentation of 16055 SOSIP trimers on these nanoparticle focuses antibody responses to an immunodominant apical epitope. Thus, these nanoparticles are a promising platform to improve the immunogenicity of Env trimers with apex-proximate NAb epitopes.Entities:
Year: 2021 PMID: 33563983 PMCID: PMC7873233 DOI: 10.1038/s41541-021-00285-9
Source DB: PubMed Journal: NPJ Vaccines ISSN: 2059-0105 Impact factor: 7.344